Abstract:1635 Background: Recruitment to phase I/II clinical trials have been reported to vary between 30% and 55% across centers, primarily relying on in-person visits. However, with the onset of the COVID-19 pandemic, there has been a noticeable surge in telehealth consultations. Consequently, there is currently a dearth of data available regarding this approach within the context of early phase-clinical trials. Methods: Data on patient’s first visits to the Investigational Cancer Therapeutics (ICT), a dedicated Phase I department at The University of Texas MD Anderson Cancer Center (MDACC), were retrieved from the institution's electronic platform. The ICT department offers phase I-II clinical trials for patients with advanced cancer. We included first visits between January 2020 and December 2023. Initial telehealth visits were conducted via video or telephone, with patients from either Texas or other states in the United States. Visits were classified into two groups: internal referrals, originating from other departments within MDACC, and new patient visits, including patients who had not been seen at MDACC prior to the ICT visit. Recruitment was defined as the percentage of patients who consented to participate in a clinical trial. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS). Results: A total of 6,965 patients had a first visit in the Investigational Cancer Therapeutics Department between January 2020 and December 2023. Of these, 4,321 patients (62%) had their initial in-person visit, while 2,644 patients (38%) opted for telehealth consultations. Internal referrals accounted for 6,304 patients (90.5%), while new patient visits comprised 661 patients (9.5%). Among the entire cohort, recruitment rate for phase I-II clinical trials was 53.2% (n= 3,702). Patients with initial telehealth consultations had a recruitment rate of 55.1%, compared to 52.0% among those with in-person consultations (χ2=6.538, p<0.011). Recruitment was higher among internal referrals at 53.7% compared to 47.5% for external referrals (χ2= 9.355, p=0.002). Notably, recruitment was statistically higher in internal consults that underwent telehealth versus in-person visits (55.4% versus 52.6%, p=0.027), while there were no statistical differences in new patient visits (47.4% vs. 47.8%, p=0.939). Conclusions: Telemedicine consultations emerge as a valuable alternative for evaluating and discussing treatment options for patients with advanced solid tumors, thereby enhancing accessibility to early-phase clinical trials. The flexibility of conducting initial visits remotely may mitigate geographical and logistical challenges and allow for a more inclusive and diverse participant pool, fostering broader representation in clinical trial research.

A Time-and-Motion Study of Clinical Trial Eligibility Screening in a Pediatric Emergency Department

Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department

Recruitment of emergency department patients to a prospective observational study

Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.

"The Truth Is, We Must Miss Some": A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical Trials

Abstract 1: Overcoming Clinical Trial Enrollment Challenges by Monitoring EMS Radio Transmissions: Pre-Hospital Screening of Acute Ischemic Stroke Patients

Patient Recruitment System for Clinical Trials: Mixed Methods Study About Requirements at Ten University Hospitals

Computational challenges and human factors influencing the design and use of clinical research participant eligibility pre-screening tools

Impact of Exigent Research Network's partnership with the Tempus AI TIME Program on the screening and matching of patients for clinical trials.

Comparison of recruitment methodologies for clinical trials: Results from the time for living and caring (TLC) intervention study

Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team

Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials

Uncovering key clinical trial features influencing recruitment

Accelerating the clinical trial start-up process for early-phase cancer studies: A test of process change to support rapid activation in an academic medical center.

Active vs Traditional Methods of Recruiting Children for a Clinical Trial in Rural Primary Care Clinics: A Cluster-Randomized Clinical Trial

ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening

Telehealth consultations and recruitment trends in clinical trials: A retrospective analysis at investigational cancer therapeutics, a dedicated phase I department at The University of Texas MD Anderson Cancer Center.

Piloting an automated clinical trial eligibility surveillance and provider alert system based on artificial intelligence and standard data models

Strategies to enhance pediatric clinical trial participation: A systematic review with narrative synthesis

The random dialing survey as a tool for community consultation for research involving the emergency medicine exception from informed consent

Remote Monitoring and Data Collection for Decentralized Clinical Trials